KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exact Sciences (EXAS) Shares Outstanding (Weighted Average): 2009-2025

Historic Shares Outstanding (Weighted Average) for Exact Sciences (EXAS) over the last 17 years, with Sep 2025 value amounting to $189.3 million.

  • Exact Sciences' Shares Outstanding (Weighted Average) rose 2.46% to $189.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $189.3 million, marking a year-over-year increase of 2.46%. This contributed to the annual value of $185.1 million for FY2024, which is 2.34% up from last year.
  • According to the latest figures from Q3 2025, Exact Sciences' Shares Outstanding (Weighted Average) is $189.3 million, which was up 0.36% from $188.6 million recorded in Q2 2025.
  • Exact Sciences' Shares Outstanding (Weighted Average)'s 5-year high stood at $189.3 million during Q3 2025, with a 5-year trough of $169.1 million in Q1 2021.
  • Moreover, its 3-year median value for Shares Outstanding (Weighted Average) was $184.5 million (2024), whereas its average is $183.6 million.
  • Data for Exact Sciences' Shares Outstanding (Weighted Average) shows a peak YoY climbed of 14.56% (in 2021) over the last 5 years.
  • Quarterly analysis of 5 years shows Exact Sciences' Shares Outstanding (Weighted Average) stood at $172.3 million in 2021, then grew by 3.11% to $177.7 million in 2022, then climbed by 1.78% to $180.8 million in 2023, then grew by 2.34% to $185.1 million in 2024, then increased by 2.46% to $189.3 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $189.3 million in Q3 2025, compared to $188.6 million in Q2 2025 and $185.8 million in Q1 2025.